Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01318967 · ClinicalTrials.gov registry record · NA
Measurement of Kidney Blood Flow and Oxygen Levels by MRI
A NA study, sponsored by Wake Forest University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01318967: Completed NA study, sponsored by Wake Forest University.
NCT01318967 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01318967, a NA study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Comparison of renal blood flow measurements by PAH clearance and MRI
Primary Outcome
Renal blood flow is estimated by the PAH method.
Interventions
- OTHER Placebo
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01318967 record still lists
NCT01318967 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01318967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01318967 about?
NCT01318967 is a clinical study titled "Measurement of Kidney Blood Flow and Oxygen Levels by MRI". Comparison of renal blood flow measurements by PAH clearance and MRI
What is the current status of trial NCT01318967?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-10. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01318967?
The interventions under investigation include: Placebo (OTHER), Furosemide (DRUG).
Who is sponsoring clinical trial NCT01318967?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01318967's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia